Mosaic ImmunoEngineering Inc. (CPMV)
USD 1.0
(66.36%)
USD 1.0
(66.36%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -690.12 Thousand | -679.23 Thousand | -760.76 Thousand | -880.28 Thousand | -1.31 Million | -1.57 Million |
| Net Income | -2.38 Million | -3.68 Million | -798.46 Thousand | -1.2 Million | -45.36 Thousand | -1.26 Million |
| Depreciation & Amortization | - | - | 489.00 | 763.00 | 826.00 | 1298.00 |
| Deferred income taxes | - | - | 26.07 Thousand | -52.15 Thousand | - | - |
| Stock-based compensation | 295.12 Thousand | 1.3 Million | -26.07 Thousand | 243.89 Thousand | - | - |
| Change in working capital | 1.64 Million | 1.51 Million | -54.3 Thousand | 133.38 Thousand | -113.45 Thousand | -15.02 Thousand |
| Other non-cash items | -249.01 Thousand | 180.94 Thousand | 91.51 Thousand | 3280.00 | -1.15 Million | -297.96 Thousand |
| Investing Cash Flow | 343 Thousand | 27.63 Thousand | -572.75 Thousand | 2.19 Million | 1.13 Million | 58.5 Thousand |
| Investments in PPE | - | - | - | -1465.00 | -2703.00 | - |
| Acquisitions | - | 27.63 Thousand | 177.24 Thousand | - | - | - |
| Investment purchases | - | - | -750 Thousand | -2.7 Million | -2.95 Million | -2.45 Million |
| Sales/Maturities of investments | - | - | 1 Million | 4.9 Million | 4.08 Million | 2.45 Million |
| Other Investing Activities | 343 Thousand | - | -1 Million | - | - | 58.5 Thousand |
| Financing Cash Flow | 341.63 Thousand | 525 Thousand | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 343 Thousand | - | - | - | - | - |
| Other Financing Activities | -1368.00 | 525 Thousand | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 19.95 Thousand | 27.49 Thousand | - | 28.25 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.62 Million | 1.48 Million | - | 105.13 Thousand | - | - |
| Cash at beginning of period | 226.14 Thousand | 352.73 Thousand | 2.31 Million | 979.64 Thousand | 1.15 Million | 2.67 Million |
| Cash at end of period | 220.64 Thousand | 226.14 Thousand | 985.92 Thousand | 2.29 Million | 979.64 Thousand | 1.15 Million |
| Capital Expenditure | - | - | - | -1465.00 | -2703.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5497.00 | -126.59 Thousand | -1.33 Million | 1.31 Million | -179.93 Thousand | -1.51 Million |
| Free Cash Flow | -690.12 Thousand | -679.23 Thousand | -760.76 Thousand | -881.75 Thousand | -1.31 Million | -1.57 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -333.24 Thousand | 19.61 Thousand | -399.04 Thousand | -2.38 Million | -534.1 Thousand | -153.65 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 5529.00 | 5469.00 | 5408.00 | 295.12 Thousand | 6529.00 | 51.59 Thousand |
| Change in working capital | 196.25 Thousand | 224.85 Thousand | 284.88 Thousand | 1.64 Million | 327.52 Thousand | 300.74 Thousand |
| Other non-cash items | 21.39 Thousand | -368.74 Thousand | -63.12 Thousand | -249.01 Thousand | 36.55 Thousand | -363.54 Thousand |
| Investing Cash Flow | - | 356 Thousand | 77 Thousand | 343 Thousand | - | 343 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 77 Thousand | 343 Thousand | - | 343 Thousand |
| Financing Cash Flow | - | - | 77 Thousand | 341.63 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 77 Thousand | 343 Thousand | 343 Thousand | - |
| Other Financing Activities | - | - | -77 Thousand | -1368.00 | -343 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -14.65 Thousand | 3166.00 | -5554.00 | 19.95 Thousand | 12.18 Thousand | -2606.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 210.9 Thousand | 221.68 Thousand | 290.44 Thousand | 1.62 Million | 315.34 Thousand | 303.35 Thousand |
| Cash at beginning of period | 362.97 Thousand | 125.77 Thousand | 220.64 Thousand | 226.14 Thousand | 384.13 Thousand | 205.99 Thousand |
| Cash at end of period | 252.89 Thousand | 362.97 Thousand | 125.77 Thousand | 220.64 Thousand | 220.64 Thousand | 384.13 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -77 Thousand | - | - | - |
| Net cash flow / Change in cash | -110.07 Thousand | 237.19 Thousand | -94.86 Thousand | -5497.00 | -163.49 Thousand | 178.14 Thousand |
| Free Cash Flow | -110.07 Thousand | -118.8 Thousand | -171.86 Thousand | -690.12 Thousand | -163.49 Thousand | -164.85 Thousand |
MOLDTECH
003960
IAR-B
EYE
ARIES
SUNS